Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Flickinger

Showing results (561-570 of 567) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 567 results.
Frontiers in Oncology|March 19, 2014
Would screening for lung cancer benefit 75- to 84-year-old residents of the United States?John M Varlotto, Malcolm M Decamp, John C Flickinger, et al.
Cancer Medicine|March 14, 2018
Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic diseaseJohn Michael Varlotto, Richard Voland, Kerrie McKie, et al.
Frontiers in Oncology|June 13, 2020
The Incidence of Node-Positive Non-small-Cell Lung Cancer Undergoing Sublobar Resection and the Role of Radiation in Its ManagementJohn M Varlotto, Isabel Emmerick, Rick Voland, et al.
Journal of Neurosurgery|October 29, 2013
The accuracy of predicting survival in individual patients with cancerDouglas Kondziolka, Phillip V Parry, L Dade Lunsford, et al.
Neuro-Oncology Advances|October 27, 2022
Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1996
Gamma knife for glioma: selection factors and survivalD A Larson, P H Gutin, M McDermott, et al.
Journal of Neuro-Oncology|November 11, 2021
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825Nirav Patil, Eashwar Somasundaram, Kristin A Waite, et al.
Pageof 57

Showing results (561-570 of 567) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 567 results.
Frontiers in Oncology|March 19, 2014
Would screening for lung cancer benefit 75- to 84-year-old residents of the United States?John M Varlotto, Malcolm M Decamp, John C Flickinger, et al.
Cancer Medicine|March 14, 2018
Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic diseaseJohn Michael Varlotto, Richard Voland, Kerrie McKie, et al.
Frontiers in Oncology|June 13, 2020
The Incidence of Node-Positive Non-small-Cell Lung Cancer Undergoing Sublobar Resection and the Role of Radiation in Its ManagementJohn M Varlotto, Isabel Emmerick, Rick Voland, et al.
Journal of Neurosurgery|October 29, 2013
The accuracy of predicting survival in individual patients with cancerDouglas Kondziolka, Phillip V Parry, L Dade Lunsford, et al.
Neuro-Oncology Advances|October 27, 2022
Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1996
Gamma knife for glioma: selection factors and survivalD A Larson, P H Gutin, M McDermott, et al.
Journal of Neuro-Oncology|November 11, 2021
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825Nirav Patil, Eashwar Somasundaram, Kristin A Waite, et al.
Pageof 57